Many of the genes identified via genetic studies and discussed here are involved in more than one pathway underlying AD pathophysiology (such as APOE, PICALM, CLU, CD2AP, TREM2, BIN1, and reported as prioritised genes in Table 2), supporting the fact that disease and therapy should be considered convergently instead of in isolation. This evidence concerns the gene PICALM and Alzheimer disease.